Navigation Links
Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
Date:8/28/2007

SEATTLE, Aug. 28 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTAX: CTIC) today announced that it had received a Deficiency Letter (the "Letter") from Nasdaq indicating that the Company's recently completed registered offering of Series C 3% Convertible Preferred Stock (the "Series C Preferred") and warrants did not comply with voting rights requirements set forth in Nasdaq Marketplace Rule 4351 and IM 4351. The Nasdaq staff verbally notified the Company of such noncompliance on August 9, 2007 and, in response to this verbal notification, the Company took action to cure the deficiency by amending the Articles of Amendment of the Company's Articles of Incorporation, which set forth the rights and preferences of the holders of the Series C Preferred (the "Articles of Amendment"). The amendment to the Articles of Amendment (the "Amendment") adjusted the conversion ratio of the Series C Preferred for purposes of the voting rights provision of the Articles of Amendment, and had the effect of reducing the number of votes that the holders of the Series C Preferred have because it increased the conversion price from $3.90 to $4.53 for purposes of the voting rights provision. The Amendment did not change the conversion price in any other provision of the Articles of Amendment, including but not limited to the provision on conversion of such Series C Preferred into shares of common stock.

The letter confirms that, subject to the public announcement requirements of Nasdaq Marketplace Rule 4803(a), the Company has regained compliance with Nasdaq Marketplace Rule 4351 and IM 4351 and the matter is now closed.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit http://www.cticseattle.com.

'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Milwaukee takes another step in electronic patient data exchange
3. Ethics Board site offers welcome contrast to state IT mistakes
4. It takes more than money to reach the top
5. CATI takes tech transfer model national
6. Green economic plan takes cue from Indiana
7. Local software company takes Google to court over a patent
8. American Family CIO takes entrepreneurial approach to innovation
9. TDS takes top spot in region in customer satisfaction rankings
10. Innovative health care takes more than just IT automation
11. Centralization mania takes over

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...2009 Complete Genomics, a third-generation human ...tion of a report in the journal Science describi...ing analysis of sequence data from three complete ...e genomes sequenced on the proof-of-principle geno...rage to $1,726 for 45x coverage for the samples de...
(Date:11/6/2009)...all/ - Microbix Biosystems Inc. (the "Company") an...F1 Certification of Annual Filings of William Gast...e Chief Financial Officer (the "Officer,s Certific...he annual audited financial statements for the yea...ially filed the annual financial statements for th...
(Date:11/6/2009)...e-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE: "...hn Docherty, president and chief operating officer...l Investor Summit on November 10, 2009 at 4:00 PM ...ty will provide an overview of the Company,s leadi...l Interferon Alpha-2b. The slide show portion of ...
(Date:11/6/2009)...RNewswire/ -- EUCODIS Bioscience, a company,develo...zymes for the,chemical industry announced today th...io Sidus, the leading biopharmaceutical company in...ODIS Bioscience exclusive access - for the search,... collection of,psychrophilic bacteria strains and ...
Breaking Biology Technology:Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2
...KEE-- NuEdge Systems , an Experian company providi...d NuEdge Suite 3.0. , ,NuEdge Suite allows compan...sumer interactions: fickle buying patterns, multi-...Suite 3.0 features: , , A data mart built from un... customer accounts, teller/POS interfaces, Web sit...
...ors Note: John Pulling, Provia,s vice president a...the Auto-ID Center, the independent organization t...Code (EPC) Technology Network, which links serial ...e. Provia Software is a Michigan-based warehouse...io frequency identification tagging (RFID). The co...
...KEE-- Hal Leonard Corporation , (HLC) headquarter...ublisher, and MakeMusic! Inc. , the leading music...t will be bundling SmartMusic with HLCs popular bo...ts 2000 for Band Book 1 and Essential Elements 200...-based music practice system with over 20,000 fun ...
Other Biology Technology:WTN Interview: John Pulling, Provia Software
Hitting the Wal-Mart RFID Deadline 2WTN Interview: John Pulling, Provia Software
Hitting the Wal-Mart RFID Deadline 3
(Date:11/4/2009)... has received more than $10 million in research gr...eral stimulus program, bringing thetotal amount of...3 million. Thirty-three projects achieved stimulu...weather. , "The university has thoughtfully unde...cholarly excellence to federal agency priorities. ...
(Date:11/4/2009).../ -- What,s the cost of saving a teenage life? Whe...g from prescription medication abuse, there,s no p...ay be unaware that the lock-boxes they,ve installe...timebomb of prescription drugs. That,s why MEDNET(...supplies, has formed an exclusive partnership with...
(Date:11/4/2009)...wire/ -- GenVault Corporation (Carlsbad, CA) today...ined its Board of Directors. Dr. Brody, the Irwin...is an acclaimed physician-scientist and university... Brody served as president of The Johns Hopkins Un...of Engineering and the Institute of Medicine, and ...
Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial 14171 1Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial 14171 2Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial 14171 3Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial 14171 4New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 1New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 2New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 3DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 1DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 2DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 3DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 4DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 5DOR BioPharma Announces 249 4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 57734 6
... starship Enterprise would deploy a deflector shie...of switching on a molecular force field of their o...ow University of Florida researchers have found a ...yme that bonds with a protein, creating a protecti...chemotherapy and promotes tumor cell survival. But...
... high levels of antibodies against the Epstein-Bar...eosis, may be more likely to develop multiple scle...osted online today that will appear in the June 20...e JAMA/Archives journals. , Researchers have long ...risk for multiple sclerosis (MS), a chronic autoim...
...T have found a new way of looking beneath the ocea...hether fish populations are shrinking. , A remote ...holas Makris of mechanical engineering, along with...val Research Laboratory, allows scientists to trac... small schools, over a 10,000-square-kilometer are...
Other Biology News:Molecular force field helps cancer cells defend against attack 2Molecular force field helps cancer cells defend against attack 3Big hips, big belly? It's in your genes, Joslin-led study shows 2One fish, two fish: New MIT sensor improves fish counts 2
... belong to the transforming growth factor- (TGF-) ... of extra-cellular growth factors which control ma...nd tumor formation (1). Other members incude TGF-s...ion factors, AMH/MIS (Anti-Mullerian Hormone/Mulle...
...ng in just seconds , No need for glass rods and ...rm spreading and more colonies, Two choices of re... spreading 100 plates or single-use tubes for 50 p...on multiple plates simultaneously ,EZ-Spread Pla...
Silencer siRNA Starter Kit from Ambion
... environment, Pipette Tracker Pro is the only pipe...c pipette calibration and record keeping within a ...requirements. Pipette Tracker Pro is a secure solu... support for Oracle and SQL Server databases, meth...
Biology Products: